The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: YF476 in Barrett's Esophagus
Official Title: Randomized, Placebo-controlled Trial of YF476, a Gastrin Receptor Antagonist, in Barrett's Esophagus
Study ID: NCT02597712
Brief Summary: A phase 2, randomised, double-blind, out-patient trial to determine if YF476 is a safe and effective treatment in patients with Barrett's esophagus.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Columbia University, Division of Digestive & Liver Diseases, New York, New York, United States
MRC Cancer Unit, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom
Name: Julian A Abrams, MD MS
Affiliation: Columbia University
Role: PRINCIPAL_INVESTIGATOR